Home/ sante SANTEMelanoma: Personalized mRNA Vaccine Reduces Recurrence RiskA custom mRNA vaccine, combined with immunotherapy, showed positive results in phase II for high-risk post-surgery patients.Published 1j·1 sourceNotable Lire en françaisListen≈ 10sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:Sciences et Avenir↗🧭Explore this topic#mélanome#vaccin#ARN messager#immunothérapie#cancer#médecine personnalisée#récidive#métastaseWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on November 20, 2026← Back to home